Probity Advisors, Inc. Moderna, Inc. Transaction History
Probity Advisors, Inc.
- $503 Million
- Q1 2025
A detailed history of Probity Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Probity Advisors, Inc. holds 14,515 shares of MRNA stock, worth $377,390. This represents 0.08% of its overall portfolio holdings.
Number of Shares
14,515
Previous 4,844
199.65%
Holding current value
$377,390
Previous $323,000
27.24%
% of portfolio
0.08%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
875Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.05 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$665 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$649 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$462 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$194 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...